Indivior shares dive on profit warning, dropping of schizophrenia drug (July 9)
(In July 9 story, corrects ticker symbol for Otsuka in paragraph 4) By Radhika Anilkumar (Reuters) -Drugmaker Indivior Plc slashed its 2024 profit forecast while signaling a slowdown in sales of its top-selling opioid addiction treatment, and said it would discontinue sales of its schizophrenia drug Perseris, prompting its shares to plunge 44% on Tuesday. …
Indivior shares dive on profit warning, dropping of schizophrenia drug (July 9) Read More »










